760 related articles for article (PubMed ID: 12287738)
1. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs.
Contracept Rep; 1994 Mar; 5(1):10-3. PubMed ID: 12287738
[TBL] [Abstract][Full Text] [Related]
2. Oral contraceptive formulation and ovarian cysts: FDA committee finds no increased risk of follicular enlargement with low-dose monophasic or triphasic preparations.
Contracept Rep; 1994 Mar; 5(1):6-9. PubMed ID: 12287739
[TBL] [Abstract][Full Text] [Related]
3. [Oral contraception: evolution of concepts over the last thirty years].
Belaisch J; Hommais-loufrani B
Contracept Fertil Sex (Paris); 1987 Nov; 15(11 Suppl):1-8. PubMed ID: 12281408
[TBL] [Abstract][Full Text] [Related]
4. [Cardiovascular risks of oral contraceptives: dose-response relationship].
Kelleher CC
Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
[TBL] [Abstract][Full Text] [Related]
5. The case for a lower dose pill. Assessing the impact of estrogen dose.
Brown S; Cropfield O
ORGYN; 1995; (2):36-9. PubMed ID: 12319251
[TBL] [Abstract][Full Text] [Related]
6. The misunderstood pill: thirty years of testing and development have reduced pill's major, minor side effects.
United States. Centers for Disease Control CDC. Advisory Committee on Immunization Practices
Netw Res Triangle Park N C; 1986; 7(4):1-5. PubMed ID: 12341093
[TBL] [Abstract][Full Text] [Related]
7. Oral contraceptives.
Maclennan AH
Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
[TBL] [Abstract][Full Text] [Related]
8. Risks of oral contraceptive use in women over 35.
Stenchever MA
J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
[TBL] [Abstract][Full Text] [Related]
9. Revised oral contraceptive labeling: FDA approves recommendation allowing delay of pelvic exam.
Contracept Rep; 1993 Nov; 4(5):4-7. PubMed ID: 12287403
[TBL] [Abstract][Full Text] [Related]
10. Three triphasic oral contraceptives now available in U.S.
Contracept Technol Update; 1985 Jan; 6(1):1-2, 4. PubMed ID: 12279912
[TBL] [Abstract][Full Text] [Related]
11. [Choosing contraception for adolescents].
Wemeau-jacquemont C
NPN Med; 1985 Feb; 5(84):185-9. PubMed ID: 12280585
[TBL] [Abstract][Full Text] [Related]
12. Estrogen component of OCs.
Kaunitz AM; Ory H
Dialogues Contracept; 1997; 5(4):1-6. PubMed ID: 12293158
[TBL] [Abstract][Full Text] [Related]
13. [Combined contraceptives and cardiovascular risk].
Belaisch J; Hommais-loufrani B
Contracept Fertil Sex (Paris); 1987 Dec; 15(12 Suppl):1-8. PubMed ID: 12315199
[TBL] [Abstract][Full Text] [Related]
14. Should oral contraceptives be sold over-the-counter?
Stone SC
Am J Gynecol Health; 1993; 7(2):27-32. PubMed ID: 12319537
[TBL] [Abstract][Full Text] [Related]
15. Berlex introduces new 20 mcg birth control pill.
Contracept Technol Update; 1998 Nov; 19(11):145-6. PubMed ID: 12294211
[TBL] [Abstract][Full Text] [Related]
16. [Oral contraception: disadvantages of estrogen reduction].
Denis C
Contracept Fertil Sex (Paris); 1993 Jun; 21(6):481-8. PubMed ID: 12318238
[TBL] [Abstract][Full Text] [Related]
17. 30 years of change: the current perspective on cardiovascular risks and oral contraceptives.
Contracept Rep; 1995 May; 6(2):4-9, 14. PubMed ID: 12319497
[TBL] [Abstract][Full Text] [Related]
18. Estrogen, progesterone dosage varies in new oral contraceptive.
Contracept Technol Update; 1984 Mar; 5(3):35-6. PubMed ID: 12312849
[TBL] [Abstract][Full Text] [Related]
19. Oral contraceptive risks: a realistic appraisal.
Bressler R; Durand JL
Drug Ther (NY); 1979 Oct; 9(10):81-95. PubMed ID: 12279276
[TBL] [Abstract][Full Text] [Related]
20. [Oral contraceptives and blood platelets].
Davenas E; Ciavatti M; Poitevin B; Aubin M
Homeopath Fr; 1985; 73(5):299-305. PubMed ID: 12281246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
